Education
About Us
Working with TipRanks
Follow Us
Intuitive Surgical (ISRG)
NASDAQ:ISRG
ISRG Analyst Ratings
Moderate Buy
16 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ISRG Stock 12 Month Forecast
Average Price Target
$641.83
▲(26.20% Upside)
| Highest Price Target$711.00 | Average Price Target$641.83 | Lowest Price Target$570.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Truist Financial
Reiterated
03/21/25
Wells Fargo
Reiterated
03/20/25
Bank of America Securities
Reiterated
03/18/25
Robert W. Baird
Reiterated
03/18/25
Morgan Stanley
Reiterated
03/18/25
Erste Group
Downgraded
03/17/25
William Blair
Reiterated
03/17/25
Raymond James
Reiterated
02/12/25
Piper Sandler
Assigned
02/03/25
Barclays
Reiterated
01/27/25
BTIG
$622
Buy
22.30%
Upside
Reiterated
01/27/25
BTIG Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)
Oppenheimer
―
Hold
―
Reiterated
01/24/25
Oppenheimer reiterates Perform Rating on Intuitive Surgical (ISRG)Oppenheimer analyst Suraj Kalia reiterated a Perform rating on Intuitive Surgical (NASDAQ: ISRG).
Leerink Partners
$590→$633
Buy
24.46%
Upside
Reiterated
01/24/25
Intuitive Surgical's Strong Performance and Growth Prospects Earn Buy RatingWe are reiterating our Outperform rating on ISRG and are increasing our price target to $633 from $590 to reflect the company's latest stellar quarter and our higher EPS estimates for FY25 and beyond. Consistent with the pre-announcement last week (see HERE), ISRG posted a stellar 4Q print, with WW sales +8% vs. consensus, and FY25 procedure growth guidance of +13-16% allowing room for upside. Of note, ISRG called out several near-term risk factors for FY25 during yesterday's earnings call, with varying degrees of potential disruption to their business. Among these, we would highlight that ISRG's current FY25 guidance does not include any potential impact from new tariffs, "which could be material" considering a significant portion of the company's instruments is currently manufactured in Mexico.
Mizuho Securities
$570
Hold
12.08%
Upside
Reiterated
01/24/25
Intuitive Surgical's Growth Priced In: Hold Rating Amid Limited Upside Potential
Stifel Nicolaus
$610→$670
Buy
31.74%
Upside
Reiterated
01/24/25
Intuitive Surgical (ISRG) PT Raised to $670 at StifelStifel analyst Rick Wise raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $670.00 (from $610.00) while maintaining a Buy rating.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
Reiterated
03/21/25
Wells Fargo
Reiterated
03/20/25
Bank of America Securities
Reiterated
03/18/25
Robert W. Baird
Reiterated
03/18/25
Morgan Stanley
Reiterated
03/18/25
Erste Group
Downgraded
03/17/25
William Blair
Reiterated
03/17/25
Raymond James
Reiterated
02/12/25
Piper Sandler
Assigned
02/03/25
Barclays
Reiterated
01/27/25
BTIG
$622
Buy
22.30%
Upside
Reiterated
01/27/25
BTIG Reaffirms Their Buy Rating on Intuitive Surgical (ISRG)
Oppenheimer
―
Hold
―
Reiterated
01/24/25
Oppenheimer reiterates Perform Rating on Intuitive Surgical (ISRG)Oppenheimer analyst Suraj Kalia reiterated a Perform rating on Intuitive Surgical (NASDAQ: ISRG).
Leerink Partners
$590→$633
Buy
24.46%
Upside
Reiterated
01/24/25
Intuitive Surgical's Strong Performance and Growth Prospects Earn Buy RatingWe are reiterating our Outperform rating on ISRG and are increasing our price target to $633 from $590 to reflect the company's latest stellar quarter and our higher EPS estimates for FY25 and beyond. Consistent with the pre-announcement last week (see HERE), ISRG posted a stellar 4Q print, with WW sales +8% vs. consensus, and FY25 procedure growth guidance of +13-16% allowing room for upside. Of note, ISRG called out several near-term risk factors for FY25 during yesterday's earnings call, with varying degrees of potential disruption to their business. Among these, we would highlight that ISRG's current FY25 guidance does not include any potential impact from new tariffs, "which could be material" considering a significant portion of the company's instruments is currently manufactured in Mexico.
Mizuho Securities
$570
Hold
12.08%
Upside
Reiterated
01/24/25
Intuitive Surgical's Growth Priced In: Hold Rating Amid Limited Upside Potential
Stifel Nicolaus
$610→$670
Buy
31.74%
Upside
Reiterated
01/24/25
Intuitive Surgical (ISRG) PT Raised to $670 at StifelStifel analyst Rick Wise raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $670.00 (from $610.00) while maintaining a Buy rating.
Best Analysts Covering Intuitive Surgical
Which Analyst Should I Follow If I Want to Buy ISRG and Sell After:
1 Month
xxx
Success Rate
14/20 ratings generated profit
Average Return
+3.80%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 70.00% of your transactions generating a profit, with an average return of +3.80% per trade.
3 Months
xxx
Success Rate
24/31 ratings generated profit
Average Return
+9.10%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 77.42% of your transactions generating a profit, with an average return of +9.10% per trade.
1 Year
Success Rate
31/35 ratings generated profit
Average Return
+29.56%
reiterated a buy rating 5 days ago
Copying Richard Newitter's trades and holding each position for 1 Year would result in 88.57% of your transactions generating a profit, with an average return of +29.56% per trade.
2 Years
xxx
Success Rate
33/35 ratings generated profit
Average Return
+69.77%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 94.29% of your transactions generating a profit, with an average return of +69.77% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ISRG Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
24
30
42
41
43
Hold
7
8
8
8
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
31
38
50
49
51
Each month's total comprises the sum of three months' worth of ratings.
ISRG Financial Forecast
ISRG Stock Forecast FAQ
What is ISRG’s average 12-month price target, according to analysts?
Based on analyst ratings, Intuitive Surgical’s 12-month average price target is $641.83.
What is ISRG’s upside potential, based on the analysts’ average price target?
Intuitive Surgical has 26.20% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ISRG a Buy, Sell or Hold?
Intuitive Surgical has a consensus rating of Moderate Buy which is based on 16 buy ratings, 6 hold ratings and 0 sell ratings.
What is Intuitive Surgical’s price target?
The average price target for Intuitive Surgical is $641.83. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $711.00 ,the lowest forecast is $570.00. The average price target represents 26.20% Increase from the current price of $508.58.
The highest analyst price target is $711.00 ,the lowest forecast is $570.00. The average price target represents 26.20% Increase from the current price of $508.58.
What do analysts say about Intuitive Surgical?
Intuitive Surgical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.
How can I buy shares of ISRG?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.